- 英文名称
- Chebulagic acid
- 分子式
- C41H30O27
- 分子量
- 954.66
- 中文别名
- 诃子鞣质; 诃子鞣质,诃子鞣酸; 坷子联苯酸; 诃子林鞣质; 诃子联苯酸; 诃黎勒酸; 2-((53S,53aS,54S,57R,58R,510S,511R,517R)-14,15,16,24,25,26,53,515,516-九羟基-52,55,513,3,8-五氧代-510-((3,4,5-三羟基苯甲酰基)氧基)-52,53,53a,54,55,57,58,510,511,513-十氢-4,7-二氧杂-5(17,8)-7,11-甲桥[1,4,7]三氧杂环十三烷并[11,10,9-de]苯并吡喃-1,2(1,2)-二苯并环辛烷-54-基)乙酸; 1-O-galloyl-2,4-O-chebuloyl-3,6-O-HHDP-β-D-glucose; 2-((53S,53aS,54S,57R,58R,510S,511R,517R)-14,15,16,24,25,26,53,515,516-Nonahydroxy-52,55,513,3,8-pentaoxo-510-((3,4,5-trihydroxybenzoyl)oxy)-52,53,53a,54,55,57,58,510,511,513-decahydro-4,7-dioxa-5(17,8)-7,11-methano[1,4,7]trioxacyclotridecino[11,10,9-de]chromena-1,2(1,2)-dibenzenacyclooctaphane-54-yl)acetic acid; [(4R,5S,7R,25S,26R,29S,30S,31S)-13,14,15,18,19,20,31,35,36-Nonahydroxy-2,10,23,28,32-pentaoxo-5-[(3,4,5-trihydroxybenzoyl)oxy]-3,6,9,24,27,33-hexaoxaheptacyclo[28.7.1.0.0.0.0 .0]octatriaconta-1(38),11,13,15,17,19,21,34,36-nonaen-29-yl]acetic acid; 1-ester with(2S)-[(3S,4S)-5-carboxy-3,4-dihydro-3,7,8-trihydroxy-2-oxo-2H-1-benzopyran-4-yl]butanedioicacid; 5:4®b-D-Glucopyranose, cyclic3,6-[(1R)-4,4',5,5',6,6'-hexahydroxy[1,1'-biphenyl]-2,2'-dicarboxylate]1-(3,4,5-trihydroxybenzoate), cyclic 2; b-D-Glucopyranose, cyclic3,6-[(1R)-4,4',5,5',6,6'-hexahydroxy[1,1'-biphenyl]-2,2'-dicarboxylate]1-(3,4,5-trihydroxybenzoate), cyclic 25:41-ester with(2S)-[(3S,4S)-5-carboxy-3,4-dihydro-3,7,8-trihydroxy-2-oxo-2H-1-benzopyran-4-yl]butanedioicacid, stereoi; β-D-Glucopyranose, cyclic 3,6-[(1R)-4,4',5,5',6,6'-hexahydroxy[1,1'-biphenyl]-2,2'-dicarboxylate] 1-(3,4,5-trihydroxybenzoate), cyclic 2→2:4→1-ester with (2S)-2-[(3S,4S)-5-carboxy-3,4-dihydro-3,7,8-trihydroxy-2-oxo-2H-1-benzopyran-4-yl]butanedioic acid; Chebulagic acid (6CI, 7CI)
- 用途
- 作为COX-LOX双重抑制剂，具有抗炎、抗感染、抗流感病毒等生物活性；用于含量测定、鉴定、药理实验等；来源于诃子、余甘子，具有抗氧化、抗肿瘤、抗病毒、抗菌、抗脂质过氧化等药理作用，是中药药效物质基础。
